Patrick J. Nolan

Array ( [id] => 3997728 [patent_doc_number] => 05858648 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Assays using reference microparticles' [patent_app_type] => 1 [patent_app_number] => 8/743164 [patent_app_country] => US [patent_app_date] => 1996-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7007 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858648.pdf [firstpage_image] =>[orig_patent_app_number] => 743164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3995034 [patent_doc_number] => 05922554 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Inhibition of cellular uptake of cholesterol' [patent_app_type] => 1 [patent_app_number] => 8/740444 [patent_app_country] => US [patent_app_date] => 1996-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17402 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922554.pdf [firstpage_image] =>[orig_patent_app_number] => 740444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4141128 [patent_doc_number] => 06063372 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Uses of mammalian CTLA-8 and related reagents' [patent_app_type] => 1 [patent_app_number] => 8/736299 [patent_app_country] => US [patent_app_date] => 1996-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7628 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063372.pdf [firstpage_image] =>[orig_patent_app_number] => 736299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1125562 [patent_doc_number] => 06790447 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-14 [patent_title] => 'Peptides for treatment of autoimmune diseases' [patent_app_type] => B1 [patent_app_number] => 08/727529 [patent_app_country] => US [patent_app_date] => 1996-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5030 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/790/06790447.pdf [firstpage_image] =>[orig_patent_app_number] => 08727529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3919957 [patent_doc_number] => 05945105 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => 'Peptides of the antigen Sm-D and their use, in particular for the diagnostics of systemic lupus erythematosus (SLE)' [patent_app_type] => 1 [patent_app_number] => 8/733982 [patent_app_country] => US [patent_app_date] => 1996-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5325 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945105.pdf [firstpage_image] =>[orig_patent_app_number] => 733982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1413865 [patent_doc_number] => 06528634 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-04 [patent_title] => 'Aiolos gene' [patent_app_type] => B1 [patent_app_number] => 08/733622 [patent_app_country] => US [patent_app_date] => 1996-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 50049 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528634.pdf [firstpage_image] =>[orig_patent_app_number] => 08733622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1098385 [patent_doc_number] => 06818214 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-16 [patent_title] => 'Two novel genes from psoriatic epidermis: psoriastatin type I and psoriastatin type II' [patent_app_type] => B2 [patent_app_number] => 08/731566 [patent_app_country] => US [patent_app_date] => 1996-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 19788 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/818/06818214.pdf [firstpage_image] =>[orig_patent_app_number] => 08731566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 680633 [patent_doc_number] => 07084260 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-01 [patent_title] => 'High affinity human antibodies and human antibodies against human antigens' [patent_app_type] => utility [patent_app_number] => 08/728463 [patent_app_country] => US [patent_app_date] => 1996-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 99 [patent_figures_cnt] => 117 [patent_no_of_words] => 84889 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/084/07084260.pdf [firstpage_image] =>[orig_patent_app_number] => 08728463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3931197 [patent_doc_number] => 05928876 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Peptide and collagen contraction inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/727311 [patent_app_country] => US [patent_app_date] => 1996-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2368 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/928/05928876.pdf [firstpage_image] =>[orig_patent_app_number] => 727311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1418464 [patent_doc_number] => 06512104 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-28 [patent_title] => 'Interleukin-1 converting enzyme like cysteine protease' [patent_app_type] => B1 [patent_app_number] => 08/724378 [patent_app_country] => US [patent_app_date] => 1996-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 12001 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/512/06512104.pdf [firstpage_image] =>[orig_patent_app_number] => 08724378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1468902 [patent_doc_number] => 06406679 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => 'Use of HL-60-related lectins in drug delivery and detection of lectin-expressing cells' [patent_app_type] => B1 [patent_app_number] => 08/719579 [patent_app_country] => US [patent_app_date] => 1996-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 12503 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/406/06406679.pdf [firstpage_image] =>[orig_patent_app_number] => 08719579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3931663 [patent_doc_number] => 05939281 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => 'Detecting alloreactivity' [patent_app_type] => 1 [patent_app_number] => 8/714728 [patent_app_country] => US [patent_app_date] => 1996-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 27 [patent_no_of_words] => 14415 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939281.pdf [firstpage_image] =>[orig_patent_app_number] => 714728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3963760 [patent_doc_number] => 05885797 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Polynucleotide sequences encoding proteins involved in myogenesis' [patent_app_type] => 1 [patent_app_number] => 8/704931 [patent_app_country] => US [patent_app_date] => 1996-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 30965 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/885/05885797.pdf [firstpage_image] =>[orig_patent_app_number] => 704931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933720 [patent_doc_number] => 05972674 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Stimulus-inducible protein kinase complex and methods of use therefor' [patent_app_type] => 1 [patent_app_number] => 8/697393 [patent_app_country] => US [patent_app_date] => 1996-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 9180 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972674.pdf [firstpage_image] =>[orig_patent_app_number] => 697393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3879036 [patent_doc_number] => 05776457 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Antibodies to human PF4A receptor and compositions thereof' [patent_app_type] => 1 [patent_app_number] => 8/701265 [patent_app_country] => US [patent_app_date] => 1996-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 23 [patent_no_of_words] => 24220 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/776/05776457.pdf [firstpage_image] =>[orig_patent_app_number] => 701265 [rel_patent_id] =>[rel_patent_doc_number] =>)